Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities

This review is intended to present perspectives from the US experience in enhancing pharmacovigilance on current practices and future opportunities. Best practices concepts could be applied worldwide through the presentation of how three pillars of pharmacovigilance: (1) medical and scientific excel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kugener, Veronique F., Freedland, Eric S., Maynard, Kenneth I., Aimer, Omar, Webster, Peggy S., Salas, Maribel, Gossell-Williams, Maxine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123099/
https://www.ncbi.nlm.nih.gov/pubmed/33993430
http://dx.doi.org/10.1007/s40264-021-01078-8
_version_ 1783692804427350016
author Kugener, Veronique F.
Freedland, Eric S.
Maynard, Kenneth I.
Aimer, Omar
Webster, Peggy S.
Salas, Maribel
Gossell-Williams, Maxine
author_facet Kugener, Veronique F.
Freedland, Eric S.
Maynard, Kenneth I.
Aimer, Omar
Webster, Peggy S.
Salas, Maribel
Gossell-Williams, Maxine
author_sort Kugener, Veronique F.
collection PubMed
description This review is intended to present perspectives from the US experience in enhancing pharmacovigilance on current practices and future opportunities. Best practices concepts could be applied worldwide through the presentation of how three pillars of pharmacovigilance: (1) medical and scientific excellence, (2) operational and compliance excellence, and (3) knowledge sharing and experts development in the field could serve as a framework for the establishment of an efficient and successful global pharmacovigilance system.
format Online
Article
Text
id pubmed-8123099
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-81230992021-05-17 Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities Kugener, Veronique F. Freedland, Eric S. Maynard, Kenneth I. Aimer, Omar Webster, Peggy S. Salas, Maribel Gossell-Williams, Maxine Drug Saf Leading Article This review is intended to present perspectives from the US experience in enhancing pharmacovigilance on current practices and future opportunities. Best practices concepts could be applied worldwide through the presentation of how three pillars of pharmacovigilance: (1) medical and scientific excellence, (2) operational and compliance excellence, and (3) knowledge sharing and experts development in the field could serve as a framework for the establishment of an efficient and successful global pharmacovigilance system. Springer International Publishing 2021-05-15 2021 /pmc/articles/PMC8123099/ /pubmed/33993430 http://dx.doi.org/10.1007/s40264-021-01078-8 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leading Article
Kugener, Veronique F.
Freedland, Eric S.
Maynard, Kenneth I.
Aimer, Omar
Webster, Peggy S.
Salas, Maribel
Gossell-Williams, Maxine
Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
title Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
title_full Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
title_fullStr Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
title_full_unstemmed Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
title_short Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
title_sort enhancing pharmacovigilance from the us experience: current practices and future opportunities
topic Leading Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123099/
https://www.ncbi.nlm.nih.gov/pubmed/33993430
http://dx.doi.org/10.1007/s40264-021-01078-8
work_keys_str_mv AT kugenerveroniquef enhancingpharmacovigilancefromtheusexperiencecurrentpracticesandfutureopportunities
AT freedlanderics enhancingpharmacovigilancefromtheusexperiencecurrentpracticesandfutureopportunities
AT maynardkennethi enhancingpharmacovigilancefromtheusexperiencecurrentpracticesandfutureopportunities
AT aimeromar enhancingpharmacovigilancefromtheusexperiencecurrentpracticesandfutureopportunities
AT websterpeggys enhancingpharmacovigilancefromtheusexperiencecurrentpracticesandfutureopportunities
AT salasmaribel enhancingpharmacovigilancefromtheusexperiencecurrentpracticesandfutureopportunities
AT gossellwilliamsmaxine enhancingpharmacovigilancefromtheusexperiencecurrentpracticesandfutureopportunities

Ejemplares similares